DK0688784T3 - Nye 3'modificerede oligonucleotid-derivater - Google Patents

Nye 3'modificerede oligonucleotid-derivater

Info

Publication number
DK0688784T3
DK0688784T3 DK95108896T DK95108896T DK0688784T3 DK 0688784 T3 DK0688784 T3 DK 0688784T3 DK 95108896 T DK95108896 T DK 95108896T DK 95108896 T DK95108896 T DK 95108896T DK 0688784 T3 DK0688784 T3 DK 0688784T3
Authority
DK
Denmark
Prior art keywords
alkyl
aryl
alkoxy
formula
nhr
Prior art date
Application number
DK95108896T
Other languages
Danish (da)
English (en)
Inventor
Eugen Dr Uhlmann
Anuschirwan Dr Peyman
Carolin Carolus
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4420737A external-priority patent/DE4420737A1/de
Priority claimed from DE4424263A external-priority patent/DE4424263A1/de
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK0688784T3 publication Critical patent/DK0688784T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/40—Succinic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK95108896T 1994-06-15 1995-06-09 Nye 3'modificerede oligonucleotid-derivater DK0688784T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4420737A DE4420737A1 (de) 1994-06-15 1994-06-15 Neue 3'-Modifizierte Oligonucleotid-Derivate
DE4424263A DE4424263A1 (de) 1994-07-09 1994-07-09 Neue 3'-Modifizierte Oligonucleotid-Derivate

Publications (1)

Publication Number Publication Date
DK0688784T3 true DK0688784T3 (da) 2006-04-18

Family

ID=25937419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95108896T DK0688784T3 (da) 1994-06-15 1995-06-09 Nye 3'modificerede oligonucleotid-derivater

Country Status (9)

Country Link
US (1) US5696248A (fr)
EP (1) EP0688784B1 (fr)
JP (1) JP4398517B2 (fr)
AT (1) ATE312840T1 (fr)
AU (1) AU701333B2 (fr)
CA (2) CA2628883C (fr)
DE (1) DE59511027D1 (fr)
DK (1) DK0688784T3 (fr)
ES (1) ES2253740T3 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291438B1 (en) 1993-02-24 2001-09-18 Jui H. Wang Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US7309692B1 (en) * 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
JP2002501505A (ja) 1997-05-05 2002-01-15 アベンティス、ファルマ、ドイチュラント、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング ヒトＨａ−ｒａｓ遺伝子断片に相補的な修飾アンチセンスヌクレオチド
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US20040186071A1 (en) 1998-04-13 2004-09-23 Bennett C. Frank Antisense modulation of CD40 expression
US5968826A (en) 1998-10-05 1999-10-19 Isis Pharmaceuticals Inc. Antisense inhibition of integrin α4 expression
WO2000040592A1 (fr) * 1998-12-30 2000-07-13 Oligos Etc. Inc. Acides nucleiques a extremites bloquees, squelette modifie et stabilite acide et leurs utilisations therapeutiques
DE10019252A1 (de) * 2000-04-18 2001-10-31 Klaus Karl Degitz Polydesoxyribonukleotide zur Hemmung der ICAM-1-Genexpression
CA2471967A1 (fr) * 2002-01-03 2003-07-31 Board Of Regents, The University Of Texas System Oligonucleotides antisens wt1 inhibant le cancer du sein
GB0209539D0 (en) * 2002-04-26 2002-06-05 Avecia Ltd Monomer Polymer and process
AR040996A1 (es) 2002-08-19 2005-04-27 Coley Pharm Group Inc Acidos nucleicos inmunoestimuladores
WO2004053104A2 (fr) 2002-12-11 2004-06-24 Coley Pharmaceutical Group, Inc. Acides nucleiques 5'cpg et leurs methodes d'utilisation
EP1611254B1 (fr) 2003-03-31 2014-09-10 Roche Diagnostics GmbH Compositions et procedes permettant de detecter certains flavivirus, notamment des membres du serogroupe du virus de l'encephalite japonaise
US8188254B2 (en) 2003-10-30 2012-05-29 Coley Pharmaceutical Gmbh C-class oligonucleotide analogs with enhanced immunostimulatory potency
MY159370A (en) 2004-10-20 2016-12-30 Coley Pharm Group Inc Semi-soft-class immunostimulatory oligonucleotides
EP1809302B1 (fr) 2004-10-20 2012-08-22 Antisense Therapeutics Ltd Modulation antisens de l'expression de l'intégrine alpha-4
PT2078080E (pt) 2006-09-27 2015-09-18 Coley Pharm Gmbh Análogos dos oligonucleotídeos cpg que contêm análogos t hidrofóbicos com atividade imunoestimulante potenciada
EP2222851B1 (fr) 2007-11-20 2017-06-28 Ionis Pharmaceuticals, Inc. Modulation de l'expression de cd40
US8889890B2 (en) 2009-09-11 2014-11-18 Segetis, Inc. Ketal esters of oxocarboxylic acids and process of making
EP2812342B1 (fr) 2012-02-08 2017-11-15 Ionis Pharmaceuticals, Inc. Modulation d'arn par ciblage de répétition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646261A (en) * 1992-01-22 1997-07-08 Hoechst Aktiengesellschaft 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
KR930016437A (ko) * 1992-01-22 1993-08-26 귀틀라인, 슈미트 올리고뉴클레오티드 유사체, 이의 제조방법 및 용도

Also Published As

Publication number Publication date
EP0688784B1 (fr) 2005-12-14
JPH0827178A (ja) 1996-01-30
EP0688784A3 (fr) 1997-01-22
CA2151801C (fr) 2008-08-19
DE59511027D1 (de) 2006-01-19
US5696248A (en) 1997-12-09
AU701333B2 (en) 1999-01-28
JP4398517B2 (ja) 2010-01-13
CA2628883C (fr) 2011-02-15
AU2165995A (en) 1995-12-21
ES2253740T3 (es) 2006-06-01
EP0688784A2 (fr) 1995-12-27
CA2151801A1 (fr) 1995-12-16
CA2628883A1 (fr) 1995-12-16
ATE312840T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
DK0688784T3 (da) Nye 3'modificerede oligonucleotid-derivater
RU2221798C2 (ru) Имидазонафтиридины, фармацевтическая композиция на их основе, способ стимуляции биосинтеза цитокина и промежуточные вещества
DE69634747D1 (de) Aryl-Ester Phosphoramidatderivate von 2',3'-Didehydronukleoside
KR960007585A (ko) 벤족사졸릴- 및 벤조티아졸릴옥사졸리디논
HUP9902576A1 (hu) Új eritromicinszármazékok, eljárás előállításukra és alkalmazásuk gyógyászati készítményekben
RU94040390A (ru) Производные виниленазаиндола, способ их получения, фармацевтическая композиция
ATE178588T1 (de) Amidino-derivate und ihre verwendung als no- synthase inhibitoren
KR930702337A (ko) 메틸렌-옥스인돌 유도체 및 이의 제조방법
NO930817L (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
HU9700579D0 (en) Novel prodrug for treating tumors and flogistic diseases
KR900700463A (ko) 6-치환 비환식 피리미딘 뉴클레오시드 유도체 및 그 유도체를 유효성분으로 하는 항 비루스재
PH23979A (en) 2,3-dihydroxy-quinolines and pharmaceutical composition containing them
CA2144475A1 (fr) Derives de polyamide-oligonucleotide; preparation et utilisation
RU2002103501A (ru) Пирроло[2,3-d] пиримидиновые нуклеозидные аналоги
DE69033223T2 (de) Derivate von 6-substituierten azyklischen Pyrimidin-Nukleosiden und diese als Wirkstoff enthaltende antivirale Mittel
DE69735845D1 (de) Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung
NO940831L (no) Diiodforbindelser for anvendelse ved fremstilling av morfolinylderivater av doxorubicin, og deres fremstilling
EE03087B1 (et) Adenosiini derivaadid, nende valmistamise meetodid ja neid sisaldavad ravimvormid
ES2051886T3 (es) Procedimiento para la obtencion de nuevos derivados de la 3h-1,2,3-triazolo(4,5-d)pirimidina.
BR9814403A (pt) "derivados do indol úteis para o tratamento, entre outros, de osteoporose"
BR9204779A (pt) Derivados de dipeptida,e processo para sua preparacao
AU5608090A (en) Amines
DK0816358T3 (da) 4-amino-2-ureidopyrimidin-5-carboxylsyreamider, fremgangsmåde til fremstilling heraf, lægemidler indeholdende sådanne forbindelser og anvendelsen af disse
HUT43064A (en) Process for producing 3-/acyl-amino-methyl/-imidazo-/1.2-a/-pyridine-derivatives and pharmaceutical preparations containing these components
DE3768469D1 (de) N-substituierte, estergruppen enthaltende acrylamide.